December 11, 2015
THERAPEUTIC UTILITY OF A NOVEL TIGHT JUNCTION MODULATING PEPTIDE FOR ENHANCING INTRANASAL DRUG DELIVERY.
This study by scientists at Nastech Pharmaceuticals demonstrated how MatTek’s EpiAirway human tracheal/bronchial tissue equivalent can be used to test the ability of a novel tight junction modulating (TJM) peptide to enhance the permeability of one low-molecular weight (LMW) drug... Read More